AASLD News

This Liver Cancer Awareness Month, AASLD spotlights an open access HEPATOLOGY special issue and resources advancing evidence-based care. ALEXANDRIA, Va. (October 6, 2026) — In recognition of Liver Cancer Awareness Month this October, the American Association for the Study of Liver Diseases (AASLD) is elevating new research, clinical guidance, and educational resources aimed at advancing the

Alexandria, Va. (Oct. 5, 2026) Today the American Association for the Study of Liver Diseases (AASLD) lifted the press embargo on abstracts submitted for The Liver Meeting® (TLM), Denver. Over 2,900 abstracts have been submitted to date. Within the submissions, topics cover 24 different topic areas including MASLD, Liver Transplantation, Liver Surgery, and Hepatitis B. The supplement provides the

New award recognizes rising leaders shaping the future of hepatology through innovation, leadership, and service. ALEXANDRIA, Va. — August 13, 2026 — The American Association for the Study of Liver Diseases (AASLD) is proud to announce the inaugural recipients of the AASLD Impact Award, a new professional recognition award celebrating mid-career members who are making significant contributions

New multidisciplinary framework helps clinicians navigate today's expanding treatment landscape for hepatocellular carcinoma. ALEXANDRIA, Virginia (August 7, 2026) — The American Association for the Study of Liver Diseases (AASLD) announces the publication of BEACON-HCC, a landmark multidisciplinary consensus now available online in HEPATOLOGY, the premier journal in liver disease. Developed by 20

This travel award provides access for people with liver disease to liver disease education, emerging research, and engagement opportunities, with a focus on individuals affected by Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Alexandria, VA – July 13, 2026 – The American Association for the Study of Liver Diseases (AASLD) proudly announces the new People Affected by Liver

Alexandria, VA – July 13, 2026 – The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest medical society funding source for liver disease research and training in the United States, announced today a funding commitment of over $2 million for over 185 grantees. This investment will fuel innovative research to advance the understanding, prevention, diagnosis, and

ALEXANDRIA, VA — The American Association for the Study of Liver Diseases (AASLD), in collaboration with the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Society of Transplantation (AST), is pleased to announce two new Practice Guidelines published in HEPATOLOGY and Liver Transplantation, AASLD’s premier scientific journals. The new

As the global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) continues to rise, AASLD remains at the forefront by providing members with the latest evidence, expert insights, clinical guidance, and educational resources to support the prevention, diagnosis, and treatment of MASLD and MASH. Join the conversation

New program empowers the medical community at the point of care to improve patient outcomes and change the trajectory of liver disease. ALEXANDRIA, VA – The American Association for the Study of Liver Diseases (AASLD) recently launched the Liver Care for Frontline Clinicians program, advancing its mission to treat and cure liver disease by extending its scientific leadership and equipping point-of

Alexandria, VA – June 5, 2026 – The American Association for the Study of Liver Diseases (AASLD) proudly announces the 2026 Distinguished Award recipients, honoring individuals whose outstanding contributions have shaped the field of hepatology and advanced the care of patients with liver disease. Each year, AASLD presents its most prestigious awards to recognize exceptional leadership, mentorship

ALEXANDRIA, Virginia — AASLD is excited to announce the 2026 Editorial Fellows for HEPATOLOGY and Liver Transplantation. Designed to help cultivate the next generation of leaders in academic publishing, this year-long fellowship offers an immersive opportunity to work alongside experienced journal editors and gain behind-the-scenes insight into the editorial processes that shape leading hepatology

Alexandria, VA – May 26, 2026 – The American Association for the Study of Liver Diseases (AASLD) is pleased to announce two new multinational consensus statements, published today in HEPATOLOGY, the premier publication in the field of liver disease. Developed through broad international collaboration, these statements provide critical guidance and help advance global alignment in hepatology

AASLD is proud to announce the 2027 leadership for the AASLD Governing Board and the AASLD Foundation Board of Trustees! These distinguished leaders bring expertise, strategic vision, and a deep dedication to advancing the field of hepatology. Their leadership will help guide AASLD and the AASLD Foundation as we continue to drive innovation, support groundbreaking research, and shape the future of

New $500,000 Stravitz Visionary Award and inaugural AASLD Impact Award strengthen support for discovery, innovation, and recognition across the hepatology community. At DDW ® 2026, AASLD and the AASLD Foundation announced two major new initiatives designed to advance the future of hepatology through strategic investment in scientific discovery and recognition of professional achievement. Together